ORIGAMI Condoms

Latex condoms were first introduced abound 1918, just 15 years after the Wright Brothers' first successful flight at Kitty Hawk. Airplane technology has advanced us to a landing on the moon and another to Mars while the condom has essentially remained the same. 

Today, almost 100 years later, condom technology has now advanced with radical re-design ideas, new materials, and signifcant functional changes for the 21st century. Three patented silicone innovations began U.S. clinical trials in the fall of 2011, with clinical research funding from the National Institutes of Allergies and Infectious Disease and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

The ORIGAMI Condoms™ brand has conducted four National Institute of Health-funded clinical trials: the first non-rolled, latex-free silicone male condom (that focuses on inside rather than outside sensation) in collaboration with the California Family with Health Council (Los Angeles); the ORIGAMI Female Condom, a latex-free, inserted female condom, in collaboration wih the California Family with Health Council (Los Angeles) and the Women's Global Health Imperative at RTI International (San Francisco); and the ORIGAMI Anal Condom, the first condom ever proposed for anal sex, in collaboration with The Fenway Institute (Boston).

Danny Resnic, the inventor and founder of ORIGAMI Condoms™, has served as principal investigator of the four NIH-funded clincial trails. The Bill & Melinda Gates Foundation  has acknowledged the company as the leading private sector innovator reinventing the condom. Danny studied design at the Art Center College of Design in Pasadena. See this article from the October 2013 issue of The Atlantic for more information.